Altered Fatty Acid Metabolism Due to Rifampicin-Resistance Conferring Mutations in therpoBGene ofMycobacterium tuberculosis: Mapping the Potential of Pharmaco-metabolomics for Global Health and Personalized Medicine-Reference-Cited by-同舟云学术

Altered Fatty Acid Metabolism Due to Rifampicin-Resistance Conferring Mutations in therpoBGene ofMycobacterium tuberculosis: Mapping the Potential of Pharmaco-metabolomics for Global Health and Personalized Medicine

Published:2012-11 Issue:11 Volume:16 Page:596-603
ISSN:1536-2310
Container-title:OMICS: A Journal of Integrative Biology
language:en
Short-container-title:OMICS: A Journal of Integrative Biology

Author:

du Preez Ilse¹²,Loots Du Toit¹

Affiliation:

1. Centre for Human Metabonomics, School for Physical and Chemical Sciences, North-West University (Potchefstroom Campus), Potchefstroom, South Africa.

2. Department of Biochemistry, School of Environmental and Health Sciences, North-West University (Mafikeng Campus), Mmabatho, South Africa.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine,Biochemistry,Biotechnology

Link

http://www.liebertpub.com/doi/pdf/10.1089/omi.2012.0028

Reference35 articles.

1. Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East

2. Acquisition of rifabutin resistance by a rifampicin resistant mutant of Mycobacterium tuberculosis involves an unusual spectrum of mutations and elevated frequency

3. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis

4. Mass spectrometry based metabolomics and enzymatic assays for functional genomics

5. Mycolic acids: structure, biosynthesis and physiological functions

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics in Pharmacometabolomics: Towards Personalized Medication;Pharmaceuticals;2023-11-07

2. Rifampicin-Mediated Metabolic Changes in Mycobacterium tuberculosis;Metabolites;2022-05-29

3. Heterogeneous fitness landscape cues, pknG low expression, and phthiocerol dimycocerosate low production of Mycobacterium tuberculosis ATCC25618 rpoB S450L in enriched broth;Tuberculosis;2022-01

4. Dihydroartemisinin-Loaded Chitosan Nanoparticles Inhibit the Rifampicin-Resistant Mycobacterium tuberculosis by Disrupting the Cell Wall;Frontiers in Microbiology;2021-09-22

5. Expression Dysregulation as a Mediator of Fitness Costs in Antibiotic Resistance;Antimicrobial Agents and Chemotherapy;2021-08-17